Truist Financial Corp Buys New Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

Truist Financial Corp bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 10,000 shares of the company’s stock, valued at approximately $315,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Nisa Investment Advisors LLC bought a new stake in Astrana Health during the third quarter worth about $35,000. New York State Teachers Retirement System bought a new position in shares of Astrana Health in the 3rd quarter worth approximately $2,515,000. QRG Capital Management Inc. purchased a new stake in shares of Astrana Health in the 3rd quarter worth $355,000. Moloney Securities Asset Management LLC bought a new position in shares of Astrana Health in the third quarter worth about $1,089,000. Finally, Amalgamated Bank bought a new position in shares of Astrana Health in the third quarter worth approximately $713,000. Institutional investors own 52.77% of the company’s stock.

Astrana Health Price Performance

Astrana Health stock opened at $27.19 on Thursday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company’s 50 day simple moving average is $34.57 and its 200-day simple moving average is $44.16. Astrana Health, Inc. has a 1 year low of $23.12 and a 1 year high of $63.20. The company has a market capitalization of $1.53 billion, a price-to-earnings ratio of 20.92, a price-to-earnings-growth ratio of 1.37 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. As a group, equities research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have commented on ASTH. Macquarie upgraded shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th. Robert W. Baird decreased their price objective on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday. Truist Financial cut their price target on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a report on Monday, January 13th. Stifel Nicolaus lowered their target price on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Finally, Bank of America decreased their price objective on Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday. Two analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $56.83.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.